{"id":"https://openalex.org/W4403785389","doi":"https://doi.org/10.1007/s40121-024-01057-3","title":"Intravenous Versus Oral Omadacycline or Linezolid for Acute Bacterial Skin and Skin Infections: A post hoc Analysis of the OASIS Trials","display_name":"Intravenous Versus Oral Omadacycline or Linezolid for Acute Bacterial Skin and Skin Infections: A post hoc Analysis of the OASIS Trials","publication_year":2024,"publication_date":"2024-10-26","ids":{"openalex":"https://openalex.org/W4403785389","doi":"https://doi.org/10.1007/s40121-024-01057-3","pmid":"https://pubmed.ncbi.nlm.nih.gov/39461915","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11582291"},"language":"en","primary_location":{"id":"doi:10.1007/s40121-024-01057-3","doi":"https://doi.org/10.1007/s40121-024-01057-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40121-024-01057-3","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40121-024-01057-3.pdf","source":{"id":"https://openalex.org/S2739130986","display_name":"Infectious Diseases and Therapy","issn_l":"2193-6382","issn":["2193-6382","2193-8229"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious Diseases and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s40121-024-01057-3.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050734777","display_name":"George David Rodriguez","orcid":"https://orcid.org/0000-0003-2209-205X","observed_orcids":["https://orcid.org/0000-0003-2209-205X"]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George D. Rodriguez","raw_affiliation_strings":["Columbia University School of Nursing, New York, NY, USA","Division of Antimicrobial Stewardship, New York-Presbyterian Queens, Flushing, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia University School of Nursing, New York, NY, USA","institution_ids":["https://openalex.org/I78577930"]},{"raw_affiliation_string":"Division of Antimicrobial Stewardship, New York-Presbyterian Queens, Flushing, NY, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047389598","display_name":"Nathan Warren","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nathan Warren","raw_affiliation_strings":["Division of Antimicrobial Stewardship, New York-Presbyterian Queens, Flushing, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Antimicrobial Stewardship, New York-Presbyterian Queens, Flushing, NY, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042748385","display_name":"Roman Yashayev","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roman Yashayev","raw_affiliation_strings":["Division of Antimicrobial Stewardship, New York-Presbyterian Queens, Flushing, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Antimicrobial Stewardship, New York-Presbyterian Queens, Flushing, NY, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062874736","display_name":"Surya Chitra","orcid":"https://orcid.org/0000-0002-5682-9200","observed_orcids":["https://orcid.org/0000-0002-5682-9200"]},"institutions":[{"id":"https://openalex.org/I4210101063","display_name":"Paratek Pharmaceuticals (United States)","ror":"https://ror.org/019g7bh20","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101063"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Surya Chitra","raw_affiliation_strings":["Paratek Pharmaceuticals, Inc., 1000 First Avenue, Suite 200, King of Prussia, PA, 19406, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paratek Pharmaceuticals, Inc., 1000 First Avenue, Suite 200, King of Prussia, PA, 19406, USA","institution_ids":["https://openalex.org/I4210101063"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053081800","display_name":"Maria I Amodio-Groton","orcid":"https://orcid.org/0000-0002-4846-9284","observed_orcids":["https://orcid.org/0000-0002-4846-9284"]},"institutions":[{"id":"https://openalex.org/I4210101063","display_name":"Paratek Pharmaceuticals (United States)","ror":"https://ror.org/019g7bh20","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101063"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria Amodio-Groton","raw_affiliation_strings":["Paratek Pharmaceuticals, Inc., 1000 First Avenue, Suite 200, King of Prussia, PA, 19406, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paratek Pharmaceuticals, Inc., 1000 First Avenue, Suite 200, King of Prussia, PA, 19406, USA","institution_ids":["https://openalex.org/I4210101063"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072370749","display_name":"Kelly Wright","orcid":"https://orcid.org/0000-0003-2908-2612","observed_orcids":["https://orcid.org/0000-0003-2908-2612"]},"institutions":[{"id":"https://openalex.org/I4210101063","display_name":"Paratek Pharmaceuticals (United States)","ror":"https://ror.org/019g7bh20","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101063"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kelly Wright","raw_affiliation_strings":["Paratek Pharmaceuticals, Inc., 1000 First Avenue, Suite 200, King of Prussia, PA, 19406, USA. Kelly.Wright@paratekpharma.com","Paratek Pharmaceuticals, Inc., 1000 First Avenue, Suite 200, King of Prussia, PA, 19406, USA"],"raw_orcid":"https://orcid.org/0000-0003-2908-2612","affiliations":[{"raw_affiliation_string":"Paratek Pharmaceuticals, Inc., 1000 First Avenue, Suite 200, King of Prussia, PA, 19406, USA. Kelly.Wright@paratekpharma.com","institution_ids":["https://openalex.org/I4210101063"]},{"raw_affiliation_string":"Paratek Pharmaceuticals, Inc., 1000 First Avenue, Suite 200, King of Prussia, PA, 19406, USA","institution_ids":["https://openalex.org/I4210101063"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5072370749"],"corresponding_institution_ids":["https://openalex.org/I4210101063"],"apc_list":{"value":6850,"currency":"USD","value_usd":6850},"apc_paid":{"value":6850,"currency":"USD","value_usd":6850},"fwci":0.8758,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.68712175,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"13","issue":"12","first_page":"2637","last_page":"2648"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.4878000020980835,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.4878000020980835,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.3005000054836273,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11153","display_name":"Streptococcal Infections and Treatments","score":0.06729999929666519,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/omadacycline","display_name":"omadacycline","score":0.8849999904632568},{"id":"https://openalex.org/keywords/linezolid","display_name":"linezolid","score":1.0},{"id":"https://openalex.org/keywords/acute-bacterial-skin-and-skin-structure-infections","display_name":"acute bacterial skin and skin structure infections","score":0.9959999918937683},{"id":"https://openalex.org/keywords/oral-antibiotic-therapy","display_name":"oral antibiotic therapy","score":0.7229999899864197},{"id":"https://openalex.org/keywords/intravenous-antibiotics","display_name":"intravenous antibiotics","score":0.746999979019165},{"id":"https://openalex.org/keywords/early-clinical-response","display_name":"early clinical response","score":0.8529999852180481},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.8560000061988831},{"id":"https://openalex.org/keywords/oasis-trial","display_name":"OASIS trial","score":0.7419999837875366},{"id":"https://openalex.org/keywords/subcutaneous-abscess","display_name":"subcutaneous abscess","score":0.7829999923706055},{"id":"https://openalex.org/keywords/nausea","display_name":"nausea","score":0.6579999923706055},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.6129999756813049},{"id":"https://openalex.org/keywords/treatment-failure","display_name":"treatment failure","score":0.31299999356269836},{"id":"https://openalex.org/keywords/lesion-size-reduction","display_name":"lesion size reduction","score":0.5979999899864197}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8914843797683716},{"id":"https://openalex.org/C2781414143","wikidata":"https://www.wikidata.org/wiki/Q411377","display_name":"Linezolid","level":5,"score":0.8825786113739014},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.6985948085784912},{"id":"https://openalex.org/C2992886853","wikidata":"https://www.wikidata.org/wiki/Q18381816","display_name":"Post hoc","level":2,"score":0.5398015975952148},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3577241897583008},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32048141956329346},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.12066051363945007},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0461115837097168},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1007/s40121-024-01057-3","doi":"https://doi.org/10.1007/s40121-024-01057-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40121-024-01057-3","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40121-024-01057-3.pdf","source":{"id":"https://openalex.org/S2739130986","display_name":"Infectious Diseases and Therapy","issn_l":"2193-6382","issn":["2193-6382","2193-8229"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious Diseases and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11582291","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11582291","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11582291/pdf/40121_2024_Article_1057.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infect Dis Ther","raw_type":"Text"},{"id":"pmid:39461915","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39461915","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious diseases and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:eafad45c321d40b98f025298c7cc9a0b","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/eafad45c321d40b98f025298c7cc9a0b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Infectious Diseases and Therapy, Vol 13, Iss 12, Pp 2637-2648 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1007/s40121-024-01057-3","doi":"https://doi.org/10.1007/s40121-024-01057-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40121-024-01057-3","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40121-024-01057-3.pdf","source":{"id":"https://openalex.org/S2739130986","display_name":"Infectious Diseases and Therapy","issn_l":"2193-6382","issn":["2193-6382","2193-8229"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious Diseases and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4403785389.pdf","grobid_xml":"https://content.openalex.org/works/W4403785389.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W40007291","https://openalex.org/W1498461177","https://openalex.org/W2002222742","https://openalex.org/W2057176680","https://openalex.org/W2069196026","https://openalex.org/W2072632770","https://openalex.org/W2116814997","https://openalex.org/W2122633654","https://openalex.org/W2136609531","https://openalex.org/W2144114125","https://openalex.org/W2158062169","https://openalex.org/W2549044887","https://openalex.org/W2752397167","https://openalex.org/W2913024914","https://openalex.org/W2939180020","https://openalex.org/W2953838561","https://openalex.org/W2964425641","https://openalex.org/W2965182241","https://openalex.org/W2966017912","https://openalex.org/W2970448618","https://openalex.org/W3001005446","https://openalex.org/W3124647333","https://openalex.org/W3135635006","https://openalex.org/W3199296880","https://openalex.org/W3200881858","https://openalex.org/W3203636445","https://openalex.org/W4205262822","https://openalex.org/W4210638555","https://openalex.org/W4220853985","https://openalex.org/W4380290951"],"related_works":["https://openalex.org/W2970448618","https://openalex.org/W4205262822","https://openalex.org/W2894507908","https://openalex.org/W2913024914","https://openalex.org/W1970983407","https://openalex.org/W2970028042","https://openalex.org/W2749521891","https://openalex.org/W2085941956","https://openalex.org/W4293111653","https://openalex.org/W7096726570"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Appropriate":[1],"oral":[2,22,44,76,102,109,266],"antibiotic":[3],"therapy":[4,78,244,250],"for":[5,86,116,168,175,265,272,275],"the":[6,29,54,169,176,196,206,263,284],"treatment":[7,23,280],"of":[8,53,72,153,198,283,286],"acute":[9],"bacterial":[10],"skin":[11,13,32],"and":[12,36,59,69,139,157,172,192,195,220,293],"structure":[14],"infections":[15,184],"(ABSSSI)":[16],"is":[17,245,255],"a":[18,269],"challenge,":[19],"as":[20,40,137,268],"current":[21],"guidelines":[24],"do":[25],"not":[26],"fully":[27],"cover":[28],"most":[30,209],"common":[31],"pathogens.":[33],"Both":[34],"linezolid":[35,85,254],"omadacycline":[37,83,95,110,252,267],"are":[38],"available":[39],"intravenous":[41,73],"or":[42,84,96,111,253],"bioequivalent":[43],"formulations.":[45],"MATERIALS":[46],"AND":[47],"METHODS:":[48],"This":[49],"post":[50],"hoc":[51],"analysis":[52],"OASIS-1":[55],"(ClinicalTrials.gov":[56,61],"identifier":[57,62],"NCT02378480)":[58],"OASIS-2":[60,107],"NCT02877927)":[63],"phase":[64],"3":[65],"trials":[66],"assessed":[67],"safety":[68],"clinical":[70,128],"efficacy":[71],"(IV)-start":[74],"versus":[75,217,225,239],"(PO)-start":[77],"in":[79,106,119,143,186,234],"patients":[80,90,105,180,276],"treated":[81],"with":[82,98],"ABSSSI.":[87],"In":[88],"OASIS-1,":[89],"were":[91,161,213],"randomized":[92],"to":[93,101,133,230,248,257],"IV":[94,249],"linezolid,":[97],"optional":[99],"switch":[100],"therapy,":[103],"while":[104],"received":[108],"linezolid.":[112],"Treatment":[113],"was":[114,125,165,203,232],"provided":[115],"7-14":[117],"days":[118],"both":[120,235],"studies.":[121],"The":[122,208],"primary":[123],"endpoint":[124],"an":[126],"early":[127],"response":[129],"(ECR)":[130],"at":[131],"48":[132],"72":[134],"h,":[135],"defined":[136],"survival":[138],"\u2265":[140],"20%":[141],"reduction":[142],"lesion":[144],"size,":[145],"without":[146],"rescue":[147],"antibacterial":[148],"therapy.":[149],"RESULTS:":[150],"A":[151],"total":[152],"645":[154],"IV-start":[155,170,191],"inpatients":[156],"735":[158],"PO-start":[159,177],"outpatients":[160],"assessed.":[162],"Median":[163],"age":[164],"47":[166],"years":[167,174],"group":[171],"44":[173],"group.":[178],"Most":[179],"had":[181],"solely":[182],"gram-positive":[183],"(97%":[185],"each":[187],"group;":[188],"ECR":[189],"[85.2%":[190],"85.0%":[193],"PO-start]),":[194],"incidence":[197],"treatment-emergent":[199],"adverse":[200],"events":[201],"(AEs)":[202],"similar":[204],"between":[205],"groups.":[207],"frequent":[210],"AEs":[211,231],"observed":[212],"nausea":[214],"(11.2%":[215],"[IV-start]":[216,224,238],"18.9%":[218],"[PO-start])":[219],"subcutaneous":[221],"abscess":[222],"(5.6%":[223],"1.9%":[226],"[PO-start]).":[227,241],"Discontinuation":[228],"due":[229],"infrequent":[233],"groups":[236],"(2%":[237],"1.2%":[240],"CONCLUSION:":[242],"Oral":[243],"equally":[246],"efficacious":[247],"when":[251],"used":[256],"treat":[258],"ABSSSIs.":[259],"These":[260],"data":[261],"strengthen":[262],"evidence":[264],"therapeutic":[270],"option":[271],"ABSSSI,":[273],"particularly":[274],"who":[277],"have":[278],"experienced":[279],"failure":[281],"because":[282],"limitations":[285],"other":[287],"therapies.":[288],"TRIAL":[289],"REGISTRATION:":[290],"Clinicaltrials.gov,":[291],"NCT02378480":[292],"NCT02877927.":[294]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2024-10-26T00:00:00"}